Fenimore Asset Management Inc lowered its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 0.6% during the 3rd quarter, Holdings Channel.com reports. The firm owned 558,284 shares of the medical research company’s stock after selling 3,091 shares during the period. Agilent Technologies accounts for 2.1% of Fenimore Asset Management Inc’s investment portfolio, making the stock its 18th largest holding. Fenimore Asset Management Inc’s holdings in Agilent Technologies were worth $96,198,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Greenleaf Trust increased its stake in shares of Agilent Technologies by 0.8% in the second quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock worth $1,078,000 after purchasing an additional 68 shares in the last quarter. Plan A Wealth LLC lifted its stake in shares of Agilent Technologies by 1.9% during the 3rd quarter. Plan A Wealth LLC now owns 3,567 shares of the medical research company’s stock valued at $615,000 after buying an additional 68 shares in the last quarter. Nilsine Partners LLC lifted its stake in shares of Agilent Technologies by 0.8% during the 2nd quarter. Nilsine Partners LLC now owns 9,650 shares of the medical research company’s stock valued at $1,282,000 after buying an additional 72 shares in the last quarter. Sapient Capital LLC boosted its holdings in Agilent Technologies by 4.2% in the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after buying an additional 85 shares during the period. Finally, Integrated Wealth Concepts LLC boosted its holdings in Agilent Technologies by 0.8% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 11,555 shares of the medical research company’s stock worth $1,535,000 after buying an additional 88 shares during the period.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on the company. JPMorgan Chase & Co. raised their price target on Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a report on Thursday, August 27th. Stifel Nicolaus upped their price objective on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Royal Bank Of Canada increased their target price on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. TD Cowen lifted their target price on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Finally, Weiss Ratings raised Agilent Technologies from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, September 11th. Fourteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $171.82.
Insider Buying and Selling
In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Agilent Technologies Price Performance
Agilent Technologies stock traded down $1.01 during mid-day trading on Thursday, reaching $168.07. 2,718,111 shares of the company’s stock traded hands, compared to its average volume of 2,278,284. The company has a market cap of $47.39 billion, a price-to-earnings ratio of 33.09, a PEG ratio of 2.58 and a beta of 1.21. The stock has a 50 day moving average of $154.62 and a two-hundred day moving average of $134.78. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $177.05.
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same quarter last year, the business earned $1.37 earnings per share. Agilent Technologies’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be given a $0.2550 dividend. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.
Agilent Technologies Company Profile
Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.
The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.
See Also
- Five stocks we like better than Agilent Technologies
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
